Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Works (13)

Eight‐color multiparameter flow cytometry (EuroFlow‐NGF) is as sensitive as next‐generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma

eJHaem
2023-02 | Journal article
DOI: 10.1002/jha2.633
Contributors: Ryota Urushihara; Naoki Takezako; Takeshi Yoroidaka; Takeshi Yamashita; Ryoichi Murata; Kenji Satou; Shinji Nakao; Hiroyuki Takamatsu
Source: check_circle
Crossref

Hematopoietic stem progenitor cells with malignancy‐related gene mutations in patients with acquired aplastic anemia are characterized by the increased expression of CXCR4

eJHaem
2022-08 | Journal article
DOI: 10.1002/jha2.515
Contributors: Takamasa Katagiri; Jorge Luis Espinoza; Mizuho Uemori; Honoka Ikeda; Kohei Hosokawa; Ken Ishiyama; Takeshi Yoroidaka; Tatsuya Imi; Hiroyuki Takamatsu; Tatsuhiko Ozawa et al.
Source: check_circle
Crossref

Guest Editorial: Innovation will be a bridge to cure in patients with multiple myeloma?

International Journal of Hematology
2022-06 | Journal article
DOI: 10.1007/s12185-022-03371-3
Contributors: Hiroyuki Takamatsu
Source: check_circle
Crossref

Revised international staging system allocation in the ICARIA‐MM study: Practical challenges and impact on outcome

eJHaem
2022-02 | Journal article
DOI: 10.1002/jha2.328
Contributors: Paul G. Richardson; Aurore Perrot; Hiroyuki Takamatsu
Source: check_circle
Crossref

Adenosine A1R/A3R (Adenosine A1 and A3 Receptor) Agonist AST-004 Reduces Brain Infarction in a Nonhuman Primate Model of Stroke

Stroke
2022-01 | Journal article
DOI: 10.1161/STROKEAHA.121.036396
Contributors: Theodore E. Liston; Aldric Hama; Johannes Boltze; Russell B. Poe; Takahiro Natsume; Ikuo Hayashi; Hiroyuki Takamatsu; William S. Korinek; James D. Lechleiter
Source: check_circle
Crossref

Disappearance of bulky diffuse large B-cell lymphoma after methotrexate/infliximab withdrawal

International Journal of Hematology
2022-01 | Journal article
DOI: 10.1007/s12185-021-03255-y
Contributors: Hiroyuki Takamatsu; Takeshi Yoroidaka
Source: check_circle
Crossref

A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survival

British Journal of Haematology
2021-10 | Journal article
DOI: 10.1111/bjh.17717
Contributors: Takeshi Yamashita; Hiroyuki Takamatsu; Koji Kawamura; Kazutaka Sunami; Shotaro Hagiwara; Mitsuhiro Itagaki; Tsutomu Takahashi; Tadakazu Kondo; Takashi Ikeda; Kyoko Watakabe‐Inamoto et al.
Source: check_circle
Crossref

Daratumumab, lenalidomide, and dexamethasone in Japanese patients with transplant-ineligible newly diagnosed multiple myeloma: a phase 1b study

International Journal of Hematology
2020-05-30 | Journal article
DOI: 10.1007/s12185-020-02825-w
Contributors: Hiroyuki Takamatsu; Shinsuke Iida; Hirohiko Shibayama; Kazuhiro Shibayama; Hiroshi Yamazaki; Kenshi Suzuki
Source: check_circle
Crossref

Clinical value of measurable residual disease testing for multiple myeloma and implementation in Japan

International Journal of Hematology
2020-04-07 | Journal article
DOI: 10.1007/s12185-020-02828-7
Contributors: Hiroyuki Takamatsu
Source: check_circle
Crossref

Correction to: Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry

International Journal of Hematology
2019-04-21 | Journal article
DOI: 10.1007/s12185-019-02621-1
Contributors: Hiroyuki Takamatsu; Takeshi Yoroidaka; Momoko Fujisawa; Kazuya Kobori; Masako Hanawa; Takeshi Yamashita; Ryoichi Murata; Mikio Ueda; Shinji Nakao; Kosei Matsue
Source: check_circle
Crossref

Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry

International Journal of Hematology
2019-04-18 | Journal article
DOI: 10.1007/s12185-019-02615-z
Contributors: Hiroyuki Takamatsu; Takeshi Yoroidaka; Momoko Fujisawa; Kazuya Kobori; Masako Hanawa; Takeshi Yamashita; Ryoichi Murata; Mikio Ueda; Shinji Nakao; Kosei Matsue
Source: check_circle
Crossref

Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
2019-03 | Journal article
DOI: 10.1016/j.bbmt.2018.11.003
Contributors: Hiroyuki Takamatsu; Takeshi Yamashita; Shingo Kurahashi; Takayuki Saitoh; Tadakazu Kondo; Takeshi Maeda; Hideyuki Nakazawa; Makoto Murata; Tomoko Narita; Junya Kuroda et al.
Source: check_circle
Crossref

A comparison of minimal residual disease detection in autografts among ASO‐qPCR, droplet digital PCR, and next‐generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation

British Journal of Haematology
2018-11 | Journal article
DOI: 10.1111/bjh.15002
Contributors: Hiroyuki Takamatsu; Rachel K. Wee; Yoshitaka Zaimoku; Ryoichi Murata; Jianbiao Zheng; Martin Moorhead; Victoria E. H. Carlton; Katherine A. Kong; Naoki Takezako; Shigeki Ito et al.
Source: check_circle
Crossref

Peer review (22 reviews for 3 publications/grants)

Review activity for Heliyon. (3)
Review activity for International journal of hematology. (18)
Review activity for Nature reviews. (1)
How many people are using ORCID?